Patient Guide: Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 242 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03924895
Status: ACTIVE_NOT_RECRUITING
Condition: Urinary Bladder Cancer, Muscle-invasive
Phase: PHASE3

Find a Study Location Near You

This study is available at 242 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Mobile, Alabama
  • Little Rock, Arkansas
  • Fullerton, California
  • • And 239 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily